Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study

Background. Extending the administration interval of erythropoiesis-stimulating agents (ESAs) represents an opportunity to improve the efficiency of anaemia management in patients with chronic kidney disease (CKD). However, effective haemoglobin (Hb) maintenance can be challenging with epoetin alfa...

Descripción completa

Detalles Bibliográficos
Autores principales: Canaud, Bernard, Mingardi, Giulio, Braun, Johann, Aljama, Pedro, Kerr, Peter G., Locatelli, Francesco, Villa, Giuseppe, Van Vlem, Bruno, McMahon, Alan W., Kerloëguen, Cécile, Beyer, Ulrich
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Dialysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568005/
https://www.ncbi.nlm.nih.gov/pubmed/18586762
http://dx.doi.org/10.1093/ndt/gfn320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568005/
https://www.ncbi.nlm.nih.gov/pubmed/18586762
http://dx.doi.org/10.1093/ndt/gfn320

Ejemplares similares